NPCE

NeuroPace, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$12.02

Price (1 Year)

$18.35 $12.02

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %17.3 / %30
Non-compliant assets / Total market cap %14.7 / %30
Non-compliant revenue / Total income %2.4 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy.

Website

Analysis (Turkish): NPCE Hissesi Caiz mi, Helal mi? NeuroPace, Inc. Katılım Analizi